Illumina Constellation Becomes TruePath Genome

Illumina is rebranding their Constellation mapped read technology to TruePath Genome and launching it into the marketplace. Priced at $395 per genome, TruePath Genome was presented as being superior to true long read approaches for generating haplotype blocks and for resolving difficult genetic disease loci.  TruePath Genome relies on on-flowcell tagmentation of long input molecules, meaning that library prep moves entirely to the flowcell.  TruePath genome runs on NovaSeq X 10B flowcells, with one sample per lane.